Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Company News
Events
Directory
Search
Close search
Home
Company
Snapdragon Chemistry
Snapdragon Chemistry
Activities:
Research & Development
X
LinkedIn
Trending Articles
Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222
Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
ChargePoint invest in a single-use manufacturing facility to expand product line
The single-use manufacturing facility will become fully operational in June 2024, and will support the company's trio of liquid and powder transfer devices
N4 Pharma and SRI to target and treat previously unreachable human cells
The companies will collaborate to perform research to conjugate SRI’s MGS system to Nuvec to increase intracellular delivery to specific target cells.
Berry Global invests to increase production capacity for healthcare products
Berry Global Group has invested in additional assets and manufacturing capabilities to increase its healthcare production capacity by up to 30% across three of its European sites
Innovation in generics: increased efficiency through peptide API synthesis expertise
Leading Swiss pharmaceutical company Bachem explains the benefits of converging LPPS in the manufacturing of gonadotropin-releasing hormone (GnRH) analogues
Upcoming event
Cleanroom Conference UK
22–23 May 2024 | Exhibition | Birmingham, UK
See all
Related Content
Manufacturing
Cambrex completes Snapdragon Chemistry acquisition
The company continues to expand its portfolio of specialised solutions for pharmaceutical development and manufacturing
Manufacturing
Cambrex set to acquire Snapdragon Chemistry
“The acquisition of Snapdragon will accelerate our growth in the area of continuous flow process development and manufacturing"
Manufacturing
Asymchem acquires US-based Snapdragon Chemistry
“We believe continuous flow manufacturing… represents the future of pharmaceutical production,” said Dr Hao Hong, Chair & CEO of Asymchem
Manufacturing
Asymchem and Snapdragon enter global partnership
The investment partnership has provided funding for Snapdragon to complete its expansion plan to build cGMP drug substance manufacturing suites
Subscribe now